TG Therapeutics, Inc. announced the appointment of Adam Waldman as Chief Commercial Officer. Mr. Waldman brings extensive experience commercializing products in oncology and hematology, most recently as the Head of US Hematology-Oncology Marketing at Celgene Corporation, and has an extensive track record of successfully launching multiple brands. Mr. Waldman joins TG Therapeutics with more than 20 years of experience in the biotechnology and life science industries. Most recently, Mr. Waldman served as the Head of US Hematology-Oncology Marketing at Celgene Corporation where he spent the past 13 years in various roles of increasing responsibility in sales, marketing and new product strategy.